Zions Bancorporation decreased its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 3.2% during the first quarter, Holdings Channel reports. The institutional investor owned 3,330 shares of the company’s stock after selling 111 shares during the period. Zions Bancorporation’s holdings in Express Scripts Holding were worth $220,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after buying an additional 649,400 shares in the last quarter. State Street Corp boosted its position in shares of Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after buying an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its position in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after buying an additional 704,218 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Express Scripts Holding by 0.3% in the first quarter. Bank of New York Mellon Corp now owns 10,960,709 shares of the company’s stock valued at $722,420,000 after buying an additional 32,854 shares in the last quarter. Finally, Macquarie Group Ltd. boosted its position in shares of Express Scripts Holding by 2.8% in the first quarter. Macquarie Group Ltd. now owns 10,958,513 shares of the company’s stock valued at $722,275,000 after buying an additional 296,452 shares in the last quarter. 90.20% of the stock is owned by institutional investors.

Shares of Express Scripts Holding Company (NASDAQ ESRX) traded up 0.86% during midday trading on Friday, hitting $60.82. 2,898,864 shares of the stock were exchanged. The firm has a 50-day moving average of $62.73 and a 200-day moving average of $64.48. Express Scripts Holding Company has a 1-year low of $57.80 and a 1-year high of $77.61. The company has a market capitalization of $35.13 billion, a P/E ratio of 10.56 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last posted its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The firm had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. During the same period last year, the firm posted $1.57 earnings per share. Express Scripts Holding’s revenue for the quarter was up .5% compared to the same quarter last year. On average, equities analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/13/express-scripts-holding-company-esrx-position-cut-by-zions-bancorporation.html.

ESRX has been the subject of several recent analyst reports. Cowen and Company reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Morgan Stanley reduced their price objective on shares of Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating for the company in a research note on Wednesday, April 26th. BidaskClub cut shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Evercore ISI reduced their price objective on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research note on Wednesday, April 26th. Finally, Mizuho reduced their price objective on shares of Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating for the company in a research note on Tuesday, April 25th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Express Scripts Holding has a consensus rating of “Hold” and a consensus price target of $71.17.

In related news, VP Phyllis S. Anderson sold 1,100 shares of the firm’s stock in a transaction on Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at $667,368.64. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.68% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.